The Czech manufacturer of veterinary drugs Bioveta received a Russian GMP certificate

Information about certification also appeared on the  Rosselkhoznadzor website .

“The company continues to supply veterinary medications for agricultural and small domestic animals to the Russian market,” commented the company’s press service.

The manufacturer has been preparing for the inspection for the past year and a half. Production processes were rebuilt, equipment was updated, and all documentation was brought into compliance. As a result, the company managed to pass the audit. Representatives of Rosselkhoznadzor and the All-Russian State Center for Quality and Standardization of Medicines for Animals and Feed (FSBI "VGNKI") confirmed the compliance of the production processes at the enterprise with quality and safety requirements.

The pharmaceutical company Bioveta was created in 1918 on the basis of the State Institute for Epizootic Recognition and Vaccine Production. In 1995 it was privatized. Today the company produces over 200 types of vaccines, antibacterial drugs, chemotherapeutic agents, biologically active mineral supplements and vitamins for farm and domestic animals.